Lipoprotein disorder
Clinical trials for Lipoprotein disorder explained in plain language.
Never miss a new study
Get alerted when new Lipoprotein disorder trials appear
Sign up with your email to follow new studies for Lipoprotein disorder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily pill tame a hidden heart risk?
Disease control Not yet recruitingThis trial tests whether an oral drug called HRS-5346 can safely lower elevated lipoprotein(a) — a genetic risk factor for heart attacks and strokes — in adults at high cardiovascular risk. Participants will take one of two doses of the drug or a placebo for 12 weeks, and researc…
Matched conditions: LIPOPROTEIN DISORDER
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Will a new drug formula absorb better? a trial in healthy adults aims to find out
Knowledge-focused Not yet recruitingThis Phase 1 trial is testing two different formulations of an experimental drug called HRS-5346 in healthy adults aged 18 to 45. The goal is to compare how well the body absorbs each version, which helps guide future development. Participants receive both formulations in a cross…
Matched conditions: LIPOPROTEIN DISORDER
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC